Blockbusters From AbbVie, Merck, Lilly Highlight List Of 10 Drugs Subject To Price CutsInvestors Business Daily • 08/29/23
Novartis presents new long-term Leqvio® (inclisiran) data demonstrating consistent efficacy and safety beyond six yearsGlobeNewsWire • 08/28/23
5 Large Drug Stocks to Watch as New Drug Approvals & M&A Gain PaceZacks Investment Research • 08/21/23
Novartis issues EGM Invitation and Shareholder Information Brochure. Sandoz publishes Listing Prospectus ahead of proposed Spin-off voteGlobeNewsWire • 08/18/23
Novartis remibrutinib Phase III trials met their primary endpoints and showed rapid symptom control in chronic spontaneous urticariaGlobeNewsWire • 08/09/23
Novartis stock jumps after drugmaker raises full-year guidance, launches $15 billion buybackCNBC • 07/18/23
Novartis Puts Up Its Biggest Earnings Growth In Two Years; Shares PopInvestors Business Daily • 07/18/23